BTSGY yields 64.94% · JNJ yields 2.13%● Live data
📍 BTSGY pulled ahead of the other in Year 1
Combined, BTSGY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTSGY + JNJ for your $10,000?
BTS Group Holdings Public Company Limited, together with its subsidiaries, engages in mass transit, property, media, and service businesses in Thailand. The company operates in three segments: Move, Mix, and Match. It operates and maintains BTS Sky Train system; constructs, operates, installs, and maintains electric rails; and train procurement services and other related services, as well as provides bus rapid transit services. The company also offers marketing solutions through offline and online media; advertising, digital, and sales services; system installation and integration services; and insurance brokerage services for offline and online distribution channels, as well as services related to rabbit card. In addition, the company offers investment in various businesses, such as restaurant operations, construction services, golf course services, and other services businesses. Further, it invests in the securities of other companies; provides architecture and engineering work consultancy services; and manages food and beverage businesses; provides electronic payment, electronic money, and bill payment services; develops software and provides technology and system integration services; and offers CRM loyalty program and coupon kiosks. The company was formerly known as Tanayong Public Company Limited and changed its name to BTS Group Holdings Public Company Limited in May 2010. BTS Group Holdings Public Company Limited was founded in 1968 and is based in Bangkok, Thailand.
Full BTSGY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.